Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer
about
Transcriptional regulation by targeted expression of architectural transcription factor high mobility group A2 in salivary glands of transgenic miceIdentification of target genes for wild type and truncated HMGA2 in mesenchymal stem-like cells.HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinomaDerepression of HMGA2 via removal of ZBRK1/BRCA1/CtIP complex enhances mammary tumorigenesis.Generation and characterisation of a canine EGFP-HMGA2 prostate cancer in vitro model.SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.High-Mobility Group A (HMGA) Proteins and Breast Cancer.Genome-wide analysis of HMGA2 transcription factor binding sites by ChIP on chip in gastric carcinoma cells.Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers.Targeting signalling pathways for the treatment of multiple myeloma.Detection of high mobility group A2 specific mRNA in the plasma of patients affected by epithelial ovarian cancer.ANG Promotes Proliferation and Invasion of the Cell of Lung Squamous Carcinoma by Directly Up-Regulating HMGA2.HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.HMGA2 is a driver of tumor metastasis.Circulating high mobility group AT-hook 2 and pleomorphic adenoma gene 1 in blood of patients with oral squamous cell carcinoma.Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer.Effect of silencing of high mobility group A2 gene on gastric cancer MKN-45 cells.HMGA2 inhibits apoptosis through interaction with ATR-CHK1 signaling complex in human cancer cells.HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer.HMGA2 induces epithelial-to-mesenchymal transition in human hepatocellular carcinoma cells.The Critical Role of Rab31 in Cell Proliferation and Apoptosis in Cancer Progression.Propofol inhibits hepatocellular carcinoma growth and invasion through the HMGA2-mediated Wnt/β-catenin pathway.HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.Circulating cell-free high mobility group AT-hook 2 mRNA as a detection marker in the serum of colorectal cancer patients.High mobility group protein A2 overexpression indicates poor prognosis for cancer patients: a meta-analysis.siRNA-Mediated Silencing of HMGA2 Induces Apoptosis and Cell Cycle Arrest in Human Colorectal Carcinoma.Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: correlation between HMGA2 expression and white blood cell count.Expression of high mobility group A2 is associated with poor survival in hepatocellular carcinoma.Prognostic Value of HMGA2 in Human Cancers: A Meta-Analysis Based on Literatures and TCGA Datasets.HMGA2 gene silencing reduces epithelial-mesenchymal transition and lymph node metastasis in cervical cancer through inhibiting the ATR/Chk1 signaling pathway
P2860
Q28586792-9CA610AC-FA4F-4E26-BEDB-A88BC00BD6ABQ33615450-EE8DD3EC-785B-4115-8FCE-D9C86D06BA1BQ33714914-825BB8A5-A3BC-470E-A72C-19EC9F28D63AQ33717478-7743A2FF-DA3C-46AA-BE79-F7D8148B841EQ33734313-D14FE017-94A9-470F-A974-CD38587CE649Q33824136-19AFBE19-FA25-482B-926D-BBABD724DF03Q34096006-2AC0EFF4-55E5-496B-A63D-2729A856AD76Q34247211-A99F8979-952F-4FD2-8D15-0B2AD1D33345Q34810805-D33462EF-835C-4962-9901-C20A4AAEBFA6Q36150866-9ABBD41F-617A-45C7-A4D0-594098C89C99Q36326396-9ACD95E7-A98C-40A9-9F93-327F1C256FDEQ36882613-83B61E2A-C0F0-448A-9320-782CE383645CQ36978594-C30056D0-3D74-4DFC-A8C7-8CC00122E2C8Q37025050-C8CC4EFF-75B4-47D4-BB3A-9E46EA6D8413Q38709288-10DCD10D-8FE1-4696-A263-492197CE7231Q38974180-1932BE35-61B8-4F67-8066-A3A99E90EC60Q39182057-159DEE60-837A-45E2-8FC9-92C9CCE8D1C8Q39182492-7F9FEA9E-99E3-436B-AAE0-179D9BF0508AQ39248052-4FA2EB28-C3EB-4EBA-B5C0-9E48ACA1EAF0Q39915224-59495FE9-A941-49C5-A728-B1D834F9FB6FQ40657337-DB17C076-C4C9-4C93-9CA6-5A2F97CFD3FDQ42055336-0B39C0A5-740E-40C1-BB80-D48573D42EA1Q47401110-BE45E543-C115-46CD-9C78-B2A1BA58F405Q47742839-63A4CC10-1DDD-46C8-AE34-E59926EAF152Q49288145-ACE0E3D5-C2D2-4660-902C-8565F01CC8A2Q51506439-E35E5797-D514-4A8F-B72B-46DF73DD8E5DQ53328370-E5EA18E6-0842-4252-9146-55823E855627Q54316822-E7246D0B-2531-4ADB-81A5-9E0DA1F92637Q55710147-A5229275-5A86-456E-A743-CBB3E75F79C6Q58733935-B45C18CA-955B-458B-905B-67353041646E
P2860
Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2003
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression of high-mobility-gr ...... al in metastatic breast cancer
@en
Expression of high-mobility-gr ...... l in metastatic breast cancer.
@nl
type
label
Expression of high-mobility-gr ...... al in metastatic breast cancer
@en
Expression of high-mobility-gr ...... l in metastatic breast cancer.
@nl
prefLabel
Expression of high-mobility-gr ...... al in metastatic breast cancer
@en
Expression of high-mobility-gr ...... l in metastatic breast cancer.
@nl
P2093
P2860
P356
P1476
Expression of high-mobility-gr ...... al in metastatic breast cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600935
P407
P577
2003-05-01T00:00:00Z